Ionis Pharmaceuticals SEC Filings
NASDAQ: IONSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
45.28+1.98 (+4.57%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ionis Pharmaceuticals filing overview
This page lists 60 recent SEC filings by Ionis Pharmaceuticals (IONS), including 40 4, 13 8-K, 3 SCHEDULE 13G/A, 2 10-Q. The most recent quarterly report (10-Q) was filed on Jul 29, 2026. The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Sep 23, 2026.
Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
IONS SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Sep 23, 2026 | 8-K | Regulation FD Disclosure; Other Events | View on EDGAR |
| Sep 4, 2026 | 8-K | Regulation FD Disclosure; Other Events | View on EDGAR |
| Sep 4, 2026 | 8-K | Regulation FD Disclosure; Other Events | View on EDGAR |
| Sep 2, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 2, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 2, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Sep 2, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 31, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 29, 2026 | 10-Q | IONIS PHARMACEUTICALS, INC. 10-Q 06-30-2026 | View on EDGAR |
| Jul 29, 2026 | 8-K | Results of Operations and Financial Condition | View on EDGAR |
| Jul 17, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 17, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 17, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 17, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 10, 2026 | 8-K | Regulation FD Disclosure | View on EDGAR |
| Jul 9, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 9, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 9, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 9, 2026 | 8-K | Regulation FD Disclosure; Other Events | View on EDGAR |
| Jul 6, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 6, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 6, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 6, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 6, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 6, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jul 6, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jun 30, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jun 30, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jun 30, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jun 26, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jun 26, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jun 24, 2026 | 8-K | Regulation FD Disclosure; Other Events | View on EDGAR |
| Jun 16, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jun 16, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jun 12, 2026 | 8-K | Other Events | View on EDGAR |
| Jun 8, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jun 8, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Jun 8, 2026 | 8-K | Departure or Appointment of Directors or Officers; Compensatory Arrangements; Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure | View on EDGAR |
| Jun 3, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| May 28, 2026 | 8-K | Regulation FD Disclosure; Other Events | View on EDGAR |
| May 15, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| May 15, 2026 | SCHEDULE 13G/A | Beneficial ownership report (passive) (amendment) | View on EDGAR |
| May 14, 2026 | SCHEDULE 13G/A | Beneficial ownership report (passive) (amendment) | View on EDGAR |
| May 6, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| May 5, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Apr 30, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Apr 30, 2026 | SCHEDULE 13G | Beneficial ownership report (passive) | View on EDGAR |
| Apr 29, 2026 | 10-Q | IONIS PHARMACEUTICALS, INC. 10-Q 03-31-2026 | View on EDGAR |
| Apr 29, 2026 | 8-K | Results of Operations and Financial Condition | View on EDGAR |
| Apr 23, 2026 | DEF 14A | Definitive proxy statement | View on EDGAR |
| Apr 21, 2026 | 8-K | Regulation FD Disclosure; Other Events | View on EDGAR |
| Apr 17, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Apr 17, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Apr 17, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Apr 17, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Apr 2, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Apr 2, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Mar 27, 2026 | SCHEDULE 13G/A | Beneficial ownership report (passive) (amendment) | View on EDGAR |
| Mar 23, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Mar 9, 2026 | 8-K | Departure or Appointment of Directors or Officers; Compensatory Arrangements; Regulation FD Disclosure | View on EDGAR |